BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37274469)

  • 1. Competing endogenous RNA analysis identified lncRNA DSCR9 as a novel prognostic biomarker associated with metastasis and tumor microenvironment in renal cell carcinoma.
    Liu Y; Luo J; Zeng J; Liu W; Fu B; Xiong J
    Oncol Lett; 2023 Jul; 26(1):290. PubMed ID: 37274469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
    Front Oncol; 2021; 11():640150. PubMed ID: 33869028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC01480 as a Prognostic Biomarker Associated With Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma.
    Ma Y; Wu C; Deng S
    Anticancer Res; 2023 Jul; 43(7):3037-3046. PubMed ID: 37351956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
    Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
    Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Immune-Related Seven-Long Non-Coding RNA Signature for Overall Survival and Validation of the Effect of LINC01270 in Malignant Phenotypes of Clear Cell Renal Carcinoma.
    Liu C; Xiong W; Song J; Ouyang X; Fu Y
    Cancer Manag Res; 2023; 15():131-145. PubMed ID: 36820408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma.
    Zhang L; Di L; Liu J; Lei X; Gu M; Zhang W; Wang Y
    Front Genet; 2023; 14():1039813. PubMed ID: 36755568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of Long Non-coding RNAs and mRNAs in Plasma of Clear Cell Renal Cell Carcinoma Patients Using Microarray and Bioinformatic Analysis.
    Zhang B; Chu W; Wen F; Zhang L; Sun L; Hu B; Wang J; Su Q; Mei Y; Cao J; Zheng J; Mou X; Dong H; Lin X; Wang N; Ji H
    Front Oncol; 2020; 10():559730. PubMed ID: 33330027
    [No Abstract]   [Full Text] [Related]  

  • 9. A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma.
    Zhang H; Ye Q; Chen Z; Zhao C; Wu Q; Ding Y; Shao Q; Zhao Y
    Dis Markers; 2022; 2022():8928282. PubMed ID: 36438902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.
    Zhang Y; Dai J; Huang W; Chen Q; Chen W; He Q; Chen F; Zhang P
    Aging (Albany NY); 2021 Dec; 13(24):25980-26002. PubMed ID: 34958632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Investigation of Immune-Related lncRNA Landscape Reveals a Potential Long Non-Coding RNA Signature for Predicting Prognosis in Renal Cell Carcinoma.
    Liu K; Li Z; Ruan D; Wang H; Wang W; Zhang G
    Front Genet; 2022; 13():890641. PubMed ID: 35860468
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning.
    Bai Z; Lu J; Chen A; Zheng X; Wu M; Tan Z; Xie J
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma.
    Wang J; Zhang C; He W; Gou X
    J Cell Biochem; 2019 Feb; 120(2):2576-2593. PubMed ID: 30278113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma.
    Li T; Tong H; Zhu J; Qin Z; Yin S; Sun Y; Liu X; He W
    Front Med (Lausanne); 2021; 8():777507. PubMed ID: 35083240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
    Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
    Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma.
    He H; Wang N; Yi X; Tang C; Wang D
    Cell Biosci; 2017; 7():65. PubMed ID: 29214011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HAGLR, A Long Non-coding RNA of Potential Tumor Suppressive Function in Clear Cell Renal Cell Carcinoma: Diagnostic and Prognostic Implications.
    Bardhan A; Banerjee A; Pal DK; Ghosh A
    Mol Biotechnol; 2023 Nov; ():. PubMed ID: 37955777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.